Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2272PDF: 1830HTML: 834 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9312PDF: 6196HTML: 88068Fig.1b: 220Fig.1c: 222Fig.2a: 205Fig.2b: 203Fig.4: 225Fig.2c: 204Fig.3: 208Tab.1: 261Tab.2: 239Tab.3: 223Tab.4: 254Fig1a: 219 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2994PDF: 1318HTML: 2834Figure 1: 199 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1900PDF: 848HTML: 10349Figures 1,2,3: 218 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3018PDF: 898HTML: 6611Untitled: 262Untitled: 218Untitled: 233Untitled: 247 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2914PDF: 1052HTML: 5638 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4550PDF: 3730HTML: 372 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4303PDF: 1983HTML: 5509Table 1: 234 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3262PDF: 1144HTML: 1886 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2059PDF: 776HTML: 723Table1: patient's characteristics: 175Table 2: profile of each patient: 197 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3779PDF: 934HTML: 6866 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1155PDF: 607Suppl. Files: 142HTML: 473 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3595PDF: 919HTML: 1682figure 1: 188Untitled: 212 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1807PDF: 1233HTML: 329 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1424PDF: 878HTML: 5080INSTITUTE PUBLICATION COMMITTEE APPROVAL: 187 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3383PDF: 989HTML: 2989 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2300PDF: 850HTML: 1697Figure 1: 224Table 1: 236 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1596PDF: 941HTML: 2010Figure: 197Tables: 208ALL revision 1: 292response to reviewer: 201 -
ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY
49PDF: 28Suppl. Files: 6Html: 7Html Suppl. Files: 7 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2041PDF: 860HTML: 255 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3902PDF: 1720HTML: 11822Figures Haase: 236 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1464HTML: 638PDF: 873 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2555PDF: 821HTML: 1745 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1252PDF: 769Html: 112 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1172PDF: 1124HTML: 492 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2482PDF: 1221HTML: 1046 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4457PDF: 1799HTML: 1122







